Additional Supporting Information may be found in the online version of this article.

jcb_24239_sm_SupplFig1.tif227KSupplementary Figure 1. Effects of PI3k/Akt inhibitor LY294002 on expressions of EC-specific markers in EPCs. LY294002 inhibited Akt phosphorylation effectively (A), and decreased mRNA levels of EC markers, i.e. KDR, VE-cadherin, vWF and CD31 (B). The bar graphs in all panels are mean ± SD averaged from at least 3 independent experiments, * P < 0.05, **P < 0.01 vs. the corresponding controls, n ≥ 3.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.